| Megan Russell, RPH, PHARM D | |
|
140b Estate St. George, St. Croix, VI 00840 | |
| (340) 718-6784 | |
| (340) 719-6784 |
| Full Name | Megan Russell |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 140b Estate St. George, St. Croix, Virgin Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184060675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 369 (Virgin Island) | Secondary |
| 183500000X | Pharmacist | PS53233 (Florida) | Secondary |
| 183500000X | Pharmacist | 26024894A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Russell, RPH, PHARM D 140b Estate St George, Frederiksted, VI 00840 Ph: (340) 718-6784 | Megan Russell, RPH, PHARM D 140b Estate St. George, St. Croix, VI 00840 Ph: (340) 718-6784 |
News Archive
A new customised IT business management system developed by Queensland University of Technology (QUT) researchers and capable of improving the scheduling of resources and workflow in surgical theatres has been successfully demonstrated in a German hospital.
African-American, Hispanic, and economically disadvantaged patients with brain tumors are significantly less likely to be referred to high-volume hospitals that specialize in neurosurgery than other patients of similar age, the same gender, and with similar comorbidities, according to new research by Johns Hopkins doctors.
Worldwide cereal production is expected to increase in 2011-2012, but "there is uncertainty about the improvement's impact on food security because of the global economic slump and increased risks for recession," according to a U.N. Food and Agriculture Organization (FAO) report released on Thursday, the Associated Press/Washington Post reports.
Shire plc,announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 9, 2014 (one minute after 11:59 p.m., New York City time, on January 9, 2014).
Progenics Pharmaceuticals, Inc. today announced the award of a grant totaling $4,143,652 from the National Institutes of Health (NIH) for Progenics' program to develop novel monoclonal antibodies to treat Clostridium difficile (C. difficile) infection.
› Verified 8 days ago
Charles Nixon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Remainder Matriculate #1 Cane Es, St. Croix, VI 00840 Phone: 340-692-2622 Fax: 340-772-2210 | |
Dora A Rullan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Remainder Matriculate #1 Cane Es, St. Croix, VI 00840 Phone: 340-692-2622 Fax: 340-772-2210 | |
Jurene Walcott, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Remainder Matriculate #1 Cane Es, St. Croix, VI 00840 Phone: 340-692-2622 Fax: 340-772-2210 | |
Robert Williamson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Remainder Matriculate #1 Cane Es, St. Croix, VI 00840 Phone: 340-692-2622 Fax: 340-772-2210 |